1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. IPH Limited
  6. News
  7. Summary
    IPH   AU000000IPH9

IPH LIMITED

(IPH)
  Report
Delayed Australian Stock Exchange  -  09:44 2022-08-08 pm EDT
8.420 AUD   -0.59%
08/01Innate Pharma Fails to Meet Efficacy Threshold in AstraZeneca-sponsored Trial For Skin Cancer Combo Drug
MT
07/21Sanofi to Further Develop Innate Pharma's Investigational Cancer Therapy
MT
07/20Anaqua, Inc. completed the acquisition of an unknown majority stake in Practice Insight Pty Ltd. from IPH Limited.
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about IPH LIMITED
07/20Anaqua, Inc. completed the acquisition of an unknown majority stake in Practice Insight..
CI
06/21IPH Flags $1.7 Million Net Loss from Divestment of WiseTime Investment
MT
06/21Anaqua, Inc. has entered into an agreement to acquire an unknown majority stake in Prac..
CI
05/13IPH Limited's Equity Buyback Plan Extended till May 30, 2023.
CI
03/17IPH : Application for quotation of securities - IPH
PU
02/27IPH Names New Chairman
MT
02/27IPH Limited Announces Board Changes
CI
02/21IPH Limited Announces Change of Registered Office
CI
02/16IPH's Net After-Tax Profit Declines 8.4% in HY22; Shares Jump 9%
MT
02/16TRANSCRIPT : IPH Limited, H1 2022 Earnings Call, Feb 17, 2022
CI
02/16IPH : HY22 Investor Presentation
PU
02/16IPH Limited Announces Dividend for A Period of Six Months Ended December 31, 2021, Paya..
CI
02/16Tranche Update on IPH Limited's Equity Buyback Plan announced on May 8, 2018.
CI
02/16IPH Limited Reports Earnings Results for the Half Year Ended December 31, 2021
CI
2021IPH : Notification regarding unquoted securities - IPH
PU
More most relevant news
All news about IPH LIMITED
08/01Innate Pharma Fails to Meet Efficacy Threshold in AstraZeneca-sponsored Trial For Skin ..
MT
07/21Sanofi to Further Develop Innate Pharma's Investigational Cancer Therapy
MT
07/20Anaqua, Inc. completed the acquisition of an unknown majority stake in Practice Insight..
CI
06/21IPH Flags $1.7 Million Net Loss from Divestment of WiseTime Investment
MT
06/21Anaqua, Inc. has entered into an agreement to acquire an unknown majority stake in Prac..
CI
06/03AstraZeneca To Pay Innate Pharma $5 Million As Lung Cancer Drug Moves To Mid-stage Deve..
MT
05/13IPH Limited's Equity Buyback Plan Extended till May 30, 2023.
CI
05/05Macquarie Group's Annual Profit Up 56% -- Update
DJ
05/04France's Innate Pharma Plans $75 Million Offering of American Depositary Shares
MT
04/29Innate Pharma To Receive $50 Million From AstraZeneca As First Patient Dosed In Late-st..
MT
More news
News in other languages on IPH LIMITED
08/01Innate Pharma n'atteint pas le seuil d'efficacité dans un essai parrainé par AstraZenec..
07/21Sanofi va poursuivre le développement du traitement expérimental du cancer d'Innate Pha..
07/20ANAQUA, INC. A COMPLÉTÉ L'ACQUISITIO : Iph).
06/21IPH enregistre une perte nette de 1,7 million de dollars suite à la cession de l'invest..
06/03AstraZeneca versera 5 millions de dollars à Innate Pharma alors que le médicament contr..
05/13Le plan de rachat d'actions d'IPH Limited est prolongé jusqu'au 30 mai 2023.
05/04La société française Innate Pharma propose un placement de 75 millions de dollars en Am..
04/29Innate Pharma recevra 50 millions de dollars d'AstraZeneca à l'occasion de l'administra..
02/27L'IPH nomme un nouveau président
02/27IPH Limited annonce des changements au sein de son conseil d'administration
More news
Press releases
03/17IPH : Application for quotation of securities - IPH
PU
02/16IPH : HY22 Investor Presentation
PU
2021IPH : Notification regarding unquoted securities - IPH
PU
2021IPH : AGM Chairman and Managing Director Addresses
PU
2021IPH : Morgans rates IPH as Add
AQ
More press releases
Upcoming event on IPH LIMITED